SEC Tracker
Get the app

IRulya Therapeutics IRLA

IRulya Therapeutics Oct 14, 2026

Ownership stake disclosure by Foresite Capital Fund VI LP

Form
Schedule 13G
Filed
Importance
Routine
  1. Foresite Capital Fund VI LP owns 489,029 shares (4.5%)
  2. Foresite Public & Crossover Opportunities Fund I, L.P. owns 163,010 shares (1.5%)
  3. James B. Tananbaum owns 652,039 shares (6.0%)
  4. Foresite Capital Management VI, LLC owns 489,029 shares (4.5%)

Written from the Schedule 13G on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when IRulya Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Veru VERU public float $64M, Mar 31, 2025, over 18 months old
  2. Lifevantage LFVN public float $64M, Dec 31, 2025
  3. Whitehawk Therapeutics WHWK public float $65M, Jun 30, 2025
  4. Medicinova MNOV public float $62M, Jun 30, 2025
  5. Corbus Pharmaceuticals Holdings CRBP public float $68M, Jun 30, 2025